Yoshika Nagata
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Immunology top 10%
- Molecular Biology
- Cancer Research
- Co-authors
- Takeshi HanagiriYoshiki ShigematsuHidetaka UramotoMitsuhiro TakenoyamaKosei YasumotoTetsuro BabaFumihiro TanakaMasaru Takenaka
- Topics
- Immunotherapy and Immune Responses (13 papers)Lung Cancer Treatments and Mutations (11 papers)Breast Lesions and Carcinomas (8 papers)
- Journals
- SHILAP Revista de lepidopterologíaCancer ResearchClinical Cancer Research
- Partner nations
- Japan
In The Last Decade
Yoshika Nagata
44 papers receiving 695 citations
Peers
Comparison fields: 5 of 69
- Oncology 356
- Pulmonary and Respiratory Medicine 278
- Immunology 220
- Molecular Biology 146
- Cancer Research 102
Countries citing papers authored by Yoshika Nagata
This map shows the geographic impact of Yoshika Nagata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshika Nagata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshika Nagata more than expected).
Fields of papers citing papers by Yoshika Nagata
This network shows the impact of papers produced by Yoshika Nagata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshika Nagata. The network helps show where Yoshika Nagata may publish in the future.
Co-authorship network of co-authors of Yoshika Nagata
This figure shows the co-authorship network connecting the top 25 collaborators of Yoshika Nagata. A scholar is included among the top collaborators of Yoshika Nagata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshika Nagata. Yoshika Nagata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 27 | |
| 4 | 10 | |
| 5 | 8 | |
| 6 | 7 | |
| 7 | 19 | |
| 8 | 22 | |
| 9 | 6 | |
| 10 | The prognostic significance of HER2 overexpression in non-small cell lung cancer. | 32 |
| 11 | 71 | |
| 12 | 4 | |
| 13 | 14 | |
| 14 | EGFR-activating mutations are not present in breast tumors of Japanese patients. | 7 |
| 15 | 13 | |
| 16 | 2 | |
| 17 | 16 | |
| 18 | 17 | |
| 19 | 20 | |
| 20 | 19 |
About Yoshika Nagata
Yoshika Nagata is a scholar working on Dermatology, Immunology and Pulmonary and Respiratory Medicine, having authored 45 papers that have together received 706 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (13 papers), Lung Cancer Treatments and Mutations (11 papers) and Breast Lesions and Carcinomas (8 papers). The work is most often cited by research in Oncology (356 citations), Immunology (220 citations) and Pulmonary and Respiratory Medicine (278 citations). Yoshika Nagata has collaborated with scholars based in Japan. Frequent co-authors include Takeshi Hanagiri, Yoshiki Shigematsu, Hidetaka Uramoto, Mitsuhiro Takenoyama, Kosei Yasumoto, Tetsuro Baba, Fumihiro Tanaka, Masaru Takenaka, Hidehiko Shimokawa and Masakazu Sugaya. Their work appears in journals such as SHILAP Revista de lepidopterología, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.